Literature DB >> 18318758

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.

Charles H Lawrie1, Shira Gal, Heather M Dunlop, Beena Pushkaran, Amanda P Liggins, Karen Pulford, Alison H Banham, Francesco Pezzella, Jacqueline Boultwood, James S Wainscoat, Christian S R Hatton, Adrian L Harris.   

Abstract

Circulating nucleic acids have been shown to have potential as non-invasive diagnostic markers in cancer. We therefore investigated whether microRNAs also have diagnostic utility by comparing levels of tumour-associated MIRN155 (miR-155), MIRN210 (miR-210) and MIRN21 (miR-21) in serum from diffuse large B-cell lymphoma (DLBCL) patients (n = 60) with healthy controls (n = 43). Levels were higher in patient than control sera (P = 0.009, 0.02 and 0.04 respectively). Moreover, high MIRN21 expression was associated with relapse-free survival (P = 0.05). This is the first description of circulating microRNAs and suggests that microRNAs have potential as non-invasive diagnostic markers for DLBCL and possibly other cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18318758     DOI: 10.1111/j.1365-2141.2008.07077.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  653 in total

Review 1.  Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids.

Authors:  Mohammad Amin Javidi; Amir Hossein Ahmadi; Babak Bakhshinejad; Nazila Nouraee; Sadegh Babashah; Majid Sadeghizadeh
Journal:  Med Oncol       Date:  2014-11-02       Impact factor: 3.064

2.  Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients.

Authors:  Jianning Song; Zhigang Bai; Wei Han; Jun Zhang; Hua Meng; Jintao Bi; Xuemei Ma; Shiwei Han; Zhongtao Zhang
Journal:  Dig Dis Sci       Date:  2011-12-25       Impact factor: 3.199

Review 3.  Horizontal transfer of microRNAs: molecular mechanisms and clinical applications.

Authors:  Xi Chen; Hongwei Liang; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

4.  Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients.

Authors:  Eun-Jung Jung; Libero Santarpia; Juyeon Kim; Francisco J Esteva; Erica Moretti; Aman U Buzdar; Angelo Di Leo; Xiao-Feng Le; Robert C Bast; Soon-Tae Park; Lajos Pusztai; George A Calin
Journal:  Cancer       Date:  2011-10-05       Impact factor: 6.860

5.  MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma.

Authors:  Alexander Baraniskin; Jan Kuhnhenn; Uwe Schlegel; Wolf Schmiegel; Stephan Hahn; Roland Schroers
Journal:  J Neurooncol       Date:  2012-06-23       Impact factor: 4.130

Review 6.  MicroRNAs: novel biomarkers for gastrointestinal carcinomas.

Authors:  Li Xie; Xiaoping Qian; Baorui Liu
Journal:  Mol Cell Biochem       Date:  2010-04-27       Impact factor: 3.396

7.  The diagnostic value of microRNA-4787-5p and microRNA-4306 in patients with acute aortic dissection.

Authors:  Lei Wang; Shijie Zhang; Zhigao Xu; Jingjing Zhang; Li Li; Guoqiang Zhao
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Giacomo Diaz; Marta Melis; Ashley Tice; David E Kleiner; Lopa Mishra; Fausto Zamboni; Patrizia Farci
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

9.  Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

Authors:  Rui-chao Zeng; Wei Zhang; Xing-qiang Yan; Zhi-qiang Ye; En-dong Chen; Du-ping Huang; Xiao-hua Zhang; Guan-li Huang
Journal:  Med Oncol       Date:  2013-02-07       Impact factor: 3.064

Review 10.  Intercellular transport of microRNAs.

Authors:  Reinier A Boon; Kasey C Vickers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.